EMA Greenlights Drugs for MS and Spinal Muscular Atrophy
-
Cenrifki prevents MS disease progression and Itvisma delivers a healthy
gene-to-cell nuclei, addressing the root cause of SMA.
*Medscape News Europe*
1 day ago